Ohcanbohtosat - Kwok, Kenneth

A retrospective, pooled data analysis of the safety of pegaptanib sodium in the treatment of age-related macular degeneration in subjects with or without diabetes mellitus Dahkki Dombi, Theresa, Kwok, Kenneth K, Sultan, Marla B

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Relationship between clinical and patient-reported outcomes in a phase 3 trial of tofacitinib or MTX in MTX-naïve patients with rheumatoid arthritis Dahkki Fleischmann, Roy, Strand, Vibeke, Wilkinson, Bethanie, Kwok, Kenneth, Bananis, Eustratios

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Lymphoma in the Tofacitinib Rheumatoid Arthritis Clinical Development Program Dahkki Mariette, Xavier, Chen, Connie, Biswas, Pinaki, Kwok, Kenneth, Boy, Mary G.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Moral judgment modulation by disgust is bi-directionally moderated by individual sensitivity Dahkki Ong, How Hwee, Mullette-Gillman, O’Dhaniel A., Kwok, Kenneth, Lim, Julian

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib Dahkki Bird, Paul, Hall, Stephen, Nash, Peter, Connell, Carol A, Kwok, Kenneth, Witcombe, David, Thirunavukkarasu, Krishan

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Safety and maintenance of response for tofacitinib monotherapy and combination therapy in rheumatoid arthritis: an analysis of pooled data from open-label long-term extension studi... Dahkki Fleischmann, Roy, Wollenhaupt, Jürgen, Takiya, Liza, Maniccia, Anna, Kwok, Kenneth, Wang, Lisy, van Vollenhoven, Ronald F

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Dopaminergic Polymorphisms Associated with Time-on-Task Declines and Fatigue in the Psychomotor Vigilance Test Dahkki Lim, Julian, Ebstein, Richard, Tse, Chun-Yu, Monakhov, Mikhail, Lai, Poh San, Dinges, David F., Kwok, Kenneth

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Tofacitinib with conventional synthetic disease‐modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis: Patient‐reported outcomes from a Phase 3 randomized con... Dahkki Li, Zhanguo, An, Yuan, Su, Houheng, Li, Xiangpei, Xu, Jianhua, Zheng, Yi, Li, Guiye, Kwok, Kenneth, Wang, Lisy, Wu, Qizhe

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Worldwide post‐marketing safety surveillance experience with tofacitinib in ulcerative colitis Dahkki Rubin, David T., Modesto, Irene, Vermeire, Séverine, Danese, Silvio, Ng, Siew C., Kwok, Kenneth K., Koram, Nana, Jones, Thomas V.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Tofacitinib, an Oral Janus Kinase Inhibitor: Pooled Efficacy and Safety Analyses in an Australian Rheumatoid Arthritis Population Dahkki Hall, Stephen, Nash, Peter, Rischmueller, Maureen, Bossingham, David, Bird, Paul, Cook, Nicola, Witcombe, David, Soma, Koshika, Kwok, Kenneth, Thirunavukkarasu, Krishan

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Assessment of radiographic progression in patients with rheumatoid arthritis treated with tofacitinib in long-term studies Dahkki van der Heijde, Désirée, Landewé, Robert B M, Wollenhaupt, Jürgen, Strengholt, Sander, Terry, Ketti, Kwok, Kenneth, Wang, Lisy, Cohen, Stanley

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials Dahkki Panaccione, Remo, Isaacs, John D., Chen, Lea Ann, Wang, Wenjin, Marren, Amy, Kwok, Kenneth, Wang, Lisy, Chan, Gary, Su, Chinyu

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Correction to: Characterization of Creatine Kinase Levels in Tofacitinib‑Treated Patients with Ulcerative Colitis: Results from Clinical Trials Dahkki Panaccione, Remo, Isaacs, John D., Chen, Lea Ann, Wang, Wenjin, Marren, Amy, Kwok, Kenneth, Wang, Lisy, Chan, Gary, Su, Chinyu

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Tofacitinib, an oral Janus kinase inhibitor: analysis of malignancies across the rheumatoid arthritis clinical development programme Dahkki Curtis, Jeffrey R, Lee, Eun Bong, Kaplan, Irina V, Kwok, Kenneth, Geier, Jamie, Benda, Birgitta, Soma, Koshika, Wang, Lisy, Riese, Richard

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disease-modifying antirheumatic drugs Dahkki Charles-Schoeman, Christina, Burmester, Gerd, Nash, Peter, Zerbini, Cristiano A F, Soma, Koshika, Kwok, Kenneth, Hendrikx, Thijs, Bananis, Eustratios, Fleischmann, Roy

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Efficacy of tofacitinib monotherapy in methotrexate-naive patients with early or established rheumatoid arthritis Dahkki Fleischmann, Roy M, Huizinga, Tom W J, Kavanaugh, Arthur F, Wilkinson, Bethanie, Kwok, Kenneth, DeMasi, Ryan, van Vollenhoven, Ronald F

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Clinical Management of Herpes Zoster in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Receiving Tofacitinib Treatment Dahkki Winthrop, Kevin L., Curtis, Jeffrey R., Yamaoka, Kunihiro, Lee, Eun Bong, Hirose, Tomohiro, Rivas, Jose L., Kwok, Kenneth, Burmester, Gerd R.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Se... Dahkki Mueller, Ruediger B., Schulze-Koops, Hendrik, Furst, Daniel E., Cohen, Stanley B. , Kwok, Kenneth, Wang, Lisy, Killeen, Tim, von Kempis, Johannes

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Long-Term Radiographic and Patient-Reported Outcomes in Patients with Rheumatoid Arthritis Treated with Tofacitinib: ORAL Start and ORAL Scan Post-hoc Analyses Dahkki Strand, Vibeke, Kavanaugh, Arthur, Kivitz, Alan J., van der Heijde, Désirée, Kwok, Kenneth, Akylbekova, Ermeg, Soonasra, Arif, Snyder, Mark, Connell, Carol, Bananis, Eustratios, Smolen, Josef S.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib—Implications for Cardiovascular Risk and Patient Management Dahkki Sands, Bruce E, Colombel, Jean-Frédéric, Ha, Christina, Farnier, Michel, Armuzzi, Alessandro, Quirk, Daniel, Friedman, Gary S, Kwok, Kenneth, Salese, Leonardo, Su, Chinyu, Taub, Pam R

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta